Cambridge Investment Research Advisors’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.6M Buy
164,910
+5,624
+4% +$809K 0.06% 350
2025
Q4
$21.1M Sell
159,286
-65
-0% -$8.62K 0.06% 349
2025
Q3
$20.9M Sell
159,351
-996
-0.6% -$136K 0.06% 333
2025
Q2
$21.4M Buy
160,347
+7,940
+5% +$911K 0.07% 295
2025
Q1
$16.7M Buy
152,407
+22,923
+18% +$2.76M 0.06% 339
2024
Q4
$16M Sell
129,484
-6,179
-5% -$749K 0.05% 335
2024
Q3
$14.8M Sell
135,663
-14,132
-9% -$1.52M 0.05% 370
2024
Q2
$16.5M Buy
149,795
+50,341
+51% +$5.57M 0.06% 316
2024
Q1
$11.3M Buy
99,454
+3,698
+4% +$380K 0.04% 414
2023
Q4
$9.32M Buy
95,756
+3,995
+4% +$366K 0.04% 443
2023
Q3
$8.86M Buy
91,761
+2,745
+3% +$261K 0.04% 419
2023
Q2
$8.05M Sell
89,016
-899
-1% -$75.7K 0.04% 456
2023
Q1
$7.83M Sell
89,915
-8,001
-8% -$699K 0.04% 443
2022
Q4
$9.41M Buy
97,916
+517
+0.5% +$46.5K 0.05% 385
2022
Q3
$7.13M Buy
97,399
+90
+0.1% +$7.47K 0.04% 422
2022
Q2
$7.74M Buy
97,309
+1,804
+2% +$159K 0.04% 411
2022
Q1
$9.36M Buy
95,505
+1,744
+2% +$165K 0.04% 396
2021
Q4
$8.72M Sell
93,761
-1,006
-1% -$94.7K 0.04% 423
2021
Q3
$8.93M Sell
94,767
-727
-0.8% -$72.5K 0.04% 389
2021
Q2
$9.19M Buy
95,494
+2,774
+3% +$261K 0.04% 392
2021
Q1
$8.37M Buy
92,720
+9,626
+12% +$828K 0.05% 384
2020
Q4
$6.68M Buy
83,094
+3,064
+4% +$228K 0.04% 416
2020
Q3
$5.25M Buy
80,030
+7,542
+10% +$497K 0.04% 448
2020
Q2
$4.5M Sell
72,488
-12,532
-15% -$712K 0.03% 481
2020
Q1
$4.05M Sell
85,020
-3,486
-4% -$230K 0.04% 428
2019
Q4
$6.75M Buy
88,506
+11,428
+15% +$824K 0.05% 362
2019
Q3
$5.15M Buy
77,078
+4,118
+6% +$259K 0.05% 390
2019
Q2
$4.87M Buy
72,960
+487
+0.7% +$32.6K 0.04% 399
2019
Q1
$4.96M Buy
72,473
+6,483
+10% +$426K 0.05% 370
2018
Q4
$3.94M Sell
65,990
-547
-0.8% -$36.9K 0.04% 403
2018
Q3
$5.09M Buy
66,537
+277
+0.4% +$20.4K 0.05% 364
2018
Q2
$4.58M Sell
66,260
-11,056
-14% -$777K 0.05% 366
2018
Q1
$5.28M Sell
77,316
-5,059
-6% -$360K 0.06% 309
2017
Q4
$5.74M Buy
82,375
+1,197
+1% +$77.6K 0.07% 283
2017
Q3
$5.1M Buy
81,178
+4,041
+5% +$244K 0.07% 280
2017
Q2
$4.6M Buy
77,137
+7,234
+10% +$429K 0.07% 275
2017
Q1
$4.18M Buy
69,903
+10,151
+17% +$606K 0.07% 260
2016
Q4
$3.33M Sell
59,752
-11,940
-17% -$642K 0.06% 287
2016
Q3
$3.91M Buy
71,692
+5,512
+8% +$295K 0.07% 267
2016
Q2
$3.45M Buy
66,180
+5,644
+9% +$300K 0.07% 262
2016
Q1
$3.29M Buy
60,536
+5,916
+11% +$285K 0.07% 254
2015
Q4
$2.61M Buy
54,620
+2,256
+4% +$107K 0.06% 283
2015
Q3
$2.31M Sell
52,364
-843
-2% -$41.5K 0.07% 278
2015
Q2
$2.95M Buy
53,207
+361
+0.7% +$21.2K 0.08% 242
2015
Q1
$2.99M Buy
52,846
+5,125
+11% +$298K 0.09% 234
2014
Q4
$2.95M Buy
47,721
+1,501
+3% +$94K 0.09% 214
2014
Q3
$2.89M Buy
46,220
+3,675
+9% +$239K 0.09% 231
2014
Q2
$2.82M Buy
42,545
+811
+2% +$54.5K 0.1% 200
2014
Q1
$2.79M Sell
41,734
-267
-0.6% -$17.6K 0.11% 180
2013
Q4
$2.95M Buy
42,001
+2,634
+7% +$176K 0.12% 164
2013
Q3
$2.55M Buy
39,367
+2,051
+5% +$125K 0.11% 178
2013
Q2
$2.04M Buy
+37,316
New +$2.1M 0.1% 196

Other funds holding EMR